CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Open-label Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of LXP1788 Injection in Patients with Advanced Solid Tumors.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06883539
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:43.864635+00:00
Published At: 2025-03-19T00:00:00+00:00
Record Updated At: 2025-03-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Tumor Malignancies, Cancer", "Solid Cancers", "Solid Tumor Cancer", "Solid Tumor, Unspecified, Adult", "Solid Tumour", "Solid Tumors Refractory to Standard Therapy", "HCC - Hepatocellular Carcinoma", "RCC, Renal Cell Cancer", "Pancreas Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-19"
protocolSection.identificationModule.nctId: "NCT06883539"
protocolSection.identificationModule.officialTitle: "A Phase I Open-label Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of LXP1788 Injection in Patients with Advanced Solid Tumors."
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.